Abstract:Cyclometalated Ir(iii) complexes [Ir(dfppy)2(qbiH)](PF6) (1), [Ir(dfppy)2(qbim)](PF6)·H2O (2), [Ir(dfppy)2(qbio)](PF6) (3) and [Ir(dfppy)2(qbi)] (4) have been designed and prepared, in which the N^N ligands qbiH, qbim and qbio incorporate different substituent groups R on their imidazole units (H atom, CH3 group and n-C8H17 group, respectively) in order to explore the influence of the substituent groups R and the protonation/deprotonation state of imidazole units in these Ir(iii) complexes on their structures and luminescence behaviors. Crystal structures indicate that an {Ir(dfppy)2}+ unit is coordinated by neutral ligands qbiH in 1, qbim in 2 and qbio in 3, while a qbi- anion in 4. These Ir(iii) complexes show clearly different molecular stacking modes. In compound 1, neighboring [Ir(dfppy)2(qbiH)]+ cations are linked into a supramolecular chain through ππ stacking interactions between adjacent dfppy-/qbiH ligands. In 2 and 4, two neighboring iridium complex units connect each other through ππ stacking interactions between dfppy- ligands in the former, while between qbi- ligands in the latter, forming supramolecular dimers. Compared to 1, 2 and 4, compound 3 only exhibits intermolecular van der Waals interactions. At room temperature, these Ir(iii) complexes in CH2Cl2 reveal phosphorescence with a mixing of 3MLCT and 3LC characters, emissions at 558 and 585 nm for 1, 572 (or 573) and 600 nm for 2 and 3, and 546 nm for 4. Compared to 1-3, compound 4 displays relatively weak luminescence intensity. Interestingly, upon addition of NEt3/TFA, both 1 and 4 in CH2Cl2 can switch their luminescence between strong emission at 558 nm and weak emission at 546 nm, due to their acid-/base-induced structural interconversion between the protonation state and the deprotonation state of the qbiH ligand. The emissions of 1-4 in the solid state reveal different degrees of the red shift compared to their corresponding emissions in CH2Cl2, the broad emission bands at 542, 572 and 611 nm for 1, 553, 581 and 612 nm for 2, 544, 578 and 630 nm for 3, and 595 and 633 nm for 4. Based on the crystal structures of 1-4, this work discusses the luminescence modulation of these Ir(iii) complexes by varying their substituent groups or the protonation/deprotonation state of the imidazole units.

Four cyclometalated Ir(iii) complexes and insights into their luminescence, cytotoxicity and DNA/BSA binding performance

Syntheses, Crystal Structures, and Photoluminescence of a Series of Iridium(III) Complexes Containing the Pentafluorosulfanyl Group

DNA binding and evaluation of anticancer activity in vitro and in vivo of iridium(III) polypyridyl complexes

Zwitterionic Iridium Complexes: Synthesis, Luminescent Properties, and Their Application in Cell Imaging.

Mixed-ligand iridium(iii) complexes as photodynamic anticancer agents.

Cyclometalated Ir(III) complexes with styryl-BODIPY ligands showing near IR absorption/emission: preparation, study of photophysical properties and application as photodynamic/luminescence imaging materials

Triphenylamine-appended cyclometallated iridium(III) complexes: Preparation, photophysical properties and application in biology/luminescence imaging.

pH-Responsive N^C-Cyclometalated Iridium(III) Complexes: Synthesis, Photophysical Properties, Computational Results, and Bioimaging Application

Phosphorescent Cyclometalated Iridium(iii) Complexes with Mono‐, Di‐, and Tetranuclear As Two Channel Probes to Light Up the Nuclei of Living Cells

Hypoxia-Active Iridium(III) Bis-terpyridine Complexes Bearing Oligothienyl Substituents: Synthesis, Photophysics, and Phototoxicity toward Cancer Cells

Design, synthesis, and evaluation of phosphorescent Ir(III) complexes with anticancer activity.

Hydroxyl and Amino Functionalized Cyclometalated Ir(III) Complexes: Synthesis, Characterization and Cytotoxicity Studies

Dual Functions of Cyclometalated Iridium(III) Complexes: Anti-Metastasis and Lysosome-Damaged Photodynamic Therapy.

Synthesis, photophysical characterisation, quantum-chemical study and in vitro antiproliferative activity of cyclometalated Ir(III) complexes based on 3,5-dimethyl-1-phenyl-1 H-pyrazole and N,N-donor ligands

Lysosome-Targeted Cyclometalated Iridium (Iii) Anticancer Complexes Bearing Phosphine-Sulfonate Ligands

Novel Lysosome-Targeted Cyclometalated Iridium(III) Anticancer Complexes Containing Imine-N-heterocyclic Carbene Ligands: Synthesis, Spectroscopic Properties and Biological Activity

Luminescent Iridium(III) Porphyrin Complexes as Near-Infrared-Emissive Biological Probes

Synthesis, structure and optoelectronic properties of iridium(III) complexes bearing a four-membered Ir-N-C N chelate structure

Cyclometalated Ir(iii) complexes containing quinoline-benzimidazole-based N^N ancillary ligands: structural and luminescence modulation by varying the substituent groups or the protonation/deprotonation state of imidazole units.

Half-sandwich Iridium(III) Complexes with Triphenylamine-Substituted Dipyridine Frameworks and Bioactivity Applications

Fluorescent Zwitterionic Iridium(III) Complexes Containing Sulfonate Groups: Synthesis, Biological Activity and Tracking in Live Cells